Connecting Pharma and Biotech to Mayo Clinic Diagnostics

Mayo Clinic collaborates with biopharma, diagnostic, and other biotech companies to enable precision medicine through advanced diagnostics. Capabilities include support of device and new assay validation in compliance with the Clinical Laboratory Improvement Amendments (CLIA). Development of new assays guided by Mayo Clinic physicians and scientists is also available.

Access to Mayo Clinic Expertise


3,500

Laboratory and pathology tests spanning all medical subspecialties

4,878

Physicians and scientists engaged in clinical practice and research

65+

Laboratories under CAP/CLIA with dedicated directors and development technologists

250

Active projects with pharma, biotech, CROs, diagnostics, and academia